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ABSTRACT
Ethylene (ethene) is the essential ripening hormone for climacteric plants, and
consequently its detection and quantification is of considerable interest to the horticulture
industry. Its detection however is a non-trivial pursuit, traditionally requiring expensive
and inaccessible instrumentation that fail to provide in vivo information about ethylene. A
ruthenium based fluorescent probe for the selective detection of ethylene has recently been
developed, and it was envisioned that this probe could be made biocompatible by encasing
it within a protein scaffold making it an artificial metalloenzyme. To this end biotinylated
N-heterocyclic carbenes (NHCs) were synthesized, which can be appended onto the
ruthenium probe. Efforts towards the expression and purification of the protein scaffold are
also here reported.
Mycofactocin (MFT) is a ribosomally synthesized and post-translationally
modified peptide (RiPP) hypothesized to function as a redox cofactor in bacteria,
particularly the Mycobacteria genus, which includes M. tuberculosis. In order to further
elucidate the function of MFT and its associated proteins, a synthetic route was desired to
the small molecule. A viable synthetic route to MFT, pre-MFT (PMFT) and other structural
analogues is here reported.
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1. ARTIFICIAL METALLOENZYME ETHYLENE DETECTION
1.1

Introduction: Ethylene

1.1.1 Role within plants
Within plants and some bacteria, ethylene acts as the critical hormone within
several developmental processes and stress responses, such as germination, senescence,
ripening, abscission, and cell apoptosis, among others.1 Many of these processes can be
initiated by ethylene both endogenously or exogenously sensed, critical especially due to
ethylene’s central role in the ripening of climacteric (meaning ethylene dependent) fruits
such as apples, cantaloupes, bananas, and tomatoes.2 All of these exhibit a steep increase
in the amount of ethylene synthesis directly preceding the fruit ripening process, and
consequently take on the characteristics of becoming ripe; loss of chlorophyll, formation
of pigments, flavors and aromas, and softening of flesh. This occurs quite naturally,
however in modern agriculture the ripening process must be controlled and monitored in
order to prevent the spoilage of fruits en route to the consumer. While there are
technologies to scrub ethylene from controlled atmospheres, many of these are toxic and/or
unsustainable.3-5 Even with these strategies in place, post-harvest food loss has massive
implications.6
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Within plants, biosynthetic ethylene is produced from methionine in 3 steps: 1) the
conversion of methionine to S-adenosyl-L-methionine (SAM) by SAM synthetase, 2) the
formation of 1-aminocyclopropane-1-carboxylic acid (ACC) from SAM by ACC synthase
and release of methylthioladenosine (MTT), and finally 3) the conversion of ACC to
ethylene by ACC oxidase (Figure 1.1)1, 7
Following its production, ethylene is sensed by a family of membrane-associated
receptors, all of which contain some copper cofactor which most likely coordinates to
ethylene directly, although this has not directly been confirmed as discussed in further
detail further in this chapter.8-10 This presumed binding leads to a change in conformation
of the receptor, modulating associated proteins and triggering downstream effects in a
signaling cascade. How these interactions achieve downstream specificity or influence
ethylene affinity of the receptor is largely unknown, since there is a possible feedback loop
regulating receptor’s binding.9 The agroeconomic impact of ethylene makes understanding
its signaling all the more important to understand. While there is considerable interest
leveraged towards this study, there is a lack of available tools to probe ethylene within
biological systems.

2

Figure 1.1 Ethylene Biosynthetic pathway

1.1.2 Methods of detection

Ethylene is an exceedingly simple molecule, especially when compared against
other molecules that elicit similar large cellular responses. This lack of complexity makes
its detection and quantification at physiological concentration (10 ppm to 10 ppb)
exceedingly difficult. Due to the demand from the horticulture industry there have been
many developments in terms of detection, however of those advancements there are still
relatively few new methods. While there are other methods, 4 of the primary techniques
will be discussed here, those being gas chromatography, optical sensing, chemoresistive,
and chemodosimeters.
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The most broadly applied method of gaseous detection by far and away is gas
chromatography (GC). Premised on the ability to separate compounds based on their
individual ability to interact with the mobile/stationary phase, as well as the unique boiling
point of the compound, GC has the added advantage of being able to detect multiple species
in a single run, and quantitatively determine their relative abundance. The hopefully
separated compounds are quantified by some detector, such as mass spectrometry (MS),
flame ionization detector (FID), etc. Separation ability and detection limit compared to
instrument size has traditionally been the limit for GC with regards to on-site monitoring
and analysis,11 however in recent years there have been technological advancements
allowing for miniaturized GC instruments. For example, Sklorz et al recently used a
miniature GC (µGC) to detect ethylene to a resolution of a few ppm using a SnO2
chemoresistive detector, however this still required a pre-concentration apparatus
appended onto the instrument.12, 13
Infrared spectroscopy (IR) has also been utilized for detecting gaseous ethylene.
Irradiating a chamber containing the analyte and tracking the absorbed incident light at a
characteristic wavelength, there are generally two categories of optical sensors, dispersive
and non-dispersive. Nondispersive instruments operate by selecting the wavelength of
interest, modernly by means of optical fibers, and are usually inexpensive. This wavelength
selection results in a high threshold of detection and limited sensitivity, constraining their
application for ethylene detection. On the other hand, dispersive instruments, utilizing
either a prism or grating, or especially those using a laser as a light source, can be very
sensitive with low limits of detection (less than 1 ppb)14, 15, but their on-site application has
been limited by prohibitive costs.16 Similar to GC, there have been marked improvements
4

in IR detector miniaturization, such as utilizing a preconcentration step17 or refining the
broadband source to allow for better wavelength discrimination using microcrystalline
diffraction.18, 19
Another field that has been used fairly extensively for ethylene detection are
chemoresistive sensors, which are premised upon the change in the electrical
conductivity/dielectric constant following exposure to the analyte. The material for this
technique varies greatly, ranging from metal oxides, conductive polymers, or carbon
materials.20 For ethylene, the most common material are metal oxides, such as the SnO2
detector discussed with regards to the µGC.12, 13 Simply explained, many semiconducting
metal oxides are n-type, and exposure to air will coat the surface with oxygen molecules
acting to withdraw electrons. This bulk reduction of electrons from the semiconductor
forms a space charge region, consequently also forming a surface potential (Schottky
barrier). Interaction with a reducing gas, such as ethylene, leads to a release of electrons
and lowering of the Schottky barrier, which can be measured and recorded as a change in
the conductivity.20, 21 Interaction with an oxidizing gas (such as NO2 or O3) with increase
the barrier and result in a reduction of current.18
Using this strategy there have been a plethora of chemoresitive sensors that use SnO2,
as well as WO3.18 These can show limits of detection down to 1 ppm, and are comparatively
inexpensive to manufacture. One drawback however is selectivity, a critical issue that is
still being addressed.22 There are other technologies being pursued and utilized towards
gaseous detection, such as single walled carbon nanotubes, amperometric sensors, and
gravimetric sensors, however those are discussed in further detail in comprehensive
reviews.11, 16, 18
5

A recent approach to ethylene detection is the use of fluorescent molecules that
interact with ethylene in such a way to either increase in fluorescence (turn on) or to
decrease in fluorescence (turn off). The remainder of this section will be dedicated to this
approach.

1.1.3 Ethylene chemodosimeters/probes

Fluorescent probes and chemodosimeters, the primary difference being the
reversibility of the reaction leading to a response (reversible vs. irreversible respectively),
all require two primary components, those being the recognition element and the signaling
element. The recognition element must have some mechanism by which it can bind or
recognize the specific target, and the signaling element is what produces the measurable
signal. It is the recognition element that poses the greatest difficulty for fluorescent probe
design for ethylene, since it lacks the nucleophilic and electrophilic handles that other
probes rely upon.23 The singular handle that ethylene does possess is an unhindered πsystem, which can interact with various metals.
Within the biosynthetic pathway and recognition of ethylene, the key component is
the copper cofactor residing within ETR1. Containing a single copper site, ethylene is
thought to coordinate directly to the metal, with a Kd = 2.4 × 10-9 M.24, 25 The explanation
for this tight binding is provided by the Dewar, Chatt, and Duncanson model, which
describes two interactions between a metal and an olefin ligand consisting of both σdonation and π- accepting interactions. σ-donation is the donation of electron density from
the olefin π-bond into an unoccupied orbital on the metal. Simultaneously, the overlap
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between a filled orbital on the metal and the π-antibonding orbital of the olefin leads to
further donation, resulting in a net π-bond between the ligand and the metal (Figure 1.2).26

Figure 1.2 Dewar-Chatt-Duncanson hypothesis
This ability of ethylene to interact with metals has provided nature the necessary
handle to detect ethylene, and using that same handle several groups have created
fluorescent probes that can report the presence of ethylene. The first example of this was
developed by Burstyn and coworkers, who impregnated a poly(vinyl phenyl ketone)
(PVPK) film with AgBF4 and were able to observe the PVPK’s quenching upon exposure
to ethylene.27 This was explained to be the preferential interaction of the Ag (I) with
ethylene. In later works, they modified that system with other polymers and silver salts,
increasing their sensitivity and selectivity.28
Utilizing a ‘turn-on’ method, Esser and Swager used diphenylacetylene and
diphenylbutadiyne, which were quenched by the interaction of a stable Cu(I) complex.
Upon exposure to ethylene however, the coordination between the alkyne and the copper
complex was disrupted and the alkyne was no longer quenched.29 Like Burstyn, the Kodera
group utilized a coordinated Ag (I) to develop their system, where the silver ion also served
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to quench the pendant anthracene moiety.30 Upon interaction with ethylene this
coordination was disrupted, and an increase in the fluorescence was observed.
1.1.1.1 Ruthenium base ethylene chemodosimeters/probes

In 2018 a novel method of ethylene detection was reported by the Michel group,
similar to other reports in regards to taking advantage of an ethylene-metal interaction, but
unique in terms of how that interaction effects the metal and the reporter moiety.31 Up to
this time, all of the ethylene-metal reporters relied upon the transient interaction of ethylene
with the metal. With a decrease in ethylene concentration there would be a commensurate
decrease or increase in the fluorescent response, depending on the system being discussed.
This holds several advantages of course, such as iterative experiments and the ability to
reuse the developed system, however this also severely limits the detection level, such that
in all the systems so far discussed the lowest limit of detection was 1000 ppm.27-30
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Figure 1.3 Previous ethylene probes
The interaction of olefins and ruthenium differs from that of Cu (I) and Ag (I) in
that following the coordination of the olefin’s π-system, a 2+2 cycloaddition can occur
between the newly associated olefin and the one that was already bound. This creates a
metallacyclobutane, from which either a productive (forward) or unproductive (reverse)
2+2 cycloreversion occurs. If it had proceeded in the forward direction, the carbons
comprising the original olefin will now comprise the methylidine complex, reformed and
able to continue the catalytic cycle.26

9

Figure 1.4 Generalized olefin metathesis reaction
The interaction between the olefin and the metal center is influenced by the steric
and electronic character of the olefin, to a such a degree that several different classes have
been developed to predict their reactivity. Of the 4 types, outlined in Figure 1.5, ethylene
is the prototypical example of a type 1 olefin, indication that a ruthenium catalyst should
be selective for ethylene preferentially over other alkenes. Additionally, there are several
different ruthenium-based catalysts commercially available, with varying degrees of water
10

stability and rates of reactions. The predominant commercial species are shown below
(Figure 1.5).

Figure 1.5 Major Grubbs Catalysts and Olefin types, as characterized by reactivity
to Cross metathesis
With this in mind, a complex derived from a Hoveyda-Grubbs 2nd generation was
synthesized bearing a BODIPY fluorophore on the phenyl substituent (Figure 1.6). The
proximity of the metal to the fluorophore is such that the BODIPY is quenched, however
upon interaction with ethylene and subsequent cross metathesis, expulsion of the
11

fluorophore occurs. No longer being influenced by the heavy atom effect, a marked
increase in fluorescence is observed.31 While there was some background turn on observed,
limits of detections were 13 ppm and 9 ppm for BEP-4 and BEP-5 respectively.

Figure 1.6 BEP-4 and BEP-5, and release of BODIPY core following ethylene
exposure

12

These limits of detection were obtained by injecting ethylene into a sealed cuvette
while the probe was dissolved in dry toluene. This represented a major improvement for
small molecule detection of ethylene, as those values are well within the range of
physiological ethylene concentration within climacteric fruit.
Additionally, both probe variants were tested for their ability to detect
endogenously produced ethylene in physiological conditions. To achieve this the probes
were incubated with HEK239T cells and Chlamydomonas reinhardtii, and subsequently
exposed to ethylene produced directly from an adjacent chamber containing a ripe
banana/mango. Unsurprisingly, it was observed that the large lipophilic probe was
observed to localize to the outer cell membrane in both systems, outlining the cells when
visualized with confocal microscopy.31
Later that same year, Sun and Huang utilized a similar technique by appending
various fluorophores onto a 1st generation Grubbs catalyst.32 Two unique BODIPY’s were
added, as well as a pyrene-type fluorophore (Figure 1.7). Utilizing the less stable Grubbs
1 catalyst, the probes were primarily tested within a DCM solution, however they were
able to achieve detection levels of 0.9 ppm,32 which bodes well for the ability of other
fluorophores to be used in conjunction with olefin metathesis.

13

Figure 1.7 G1 type ruthenium-based ethylene probes developed by the Huang group
Despite these advances, there are marked disadvantages to using metal catalysts for
ethylene detection within cellular systems, the most poignant being water compatibility.
With the exception of the Michel report, organic solvents have been heavily featured in
probe evaluation, often using solvents that are toxic and immiscible for biological function.
Additionally, none of the probes so far mentioned have been used to test endogenously
produced ethylene within the cellular system, relying on exogenous sources regardless of
its production. In order to test endogenously produced ethylene biologically, there has been
a singular report proposing to address this issue by using an artificial metalloenzyme to
encase the metal probe.33 This is discussed in more detail following a brief review of
artificial metalloenzymes.

1.2

Introduction: Metalloenzymes

1.2.1 Metalloenzymes within nature
14

Comprised of folded polypeptide chains, enzymes are the most important type of
catalysts for biological transformations, with oftentimes unmatched specificity and
catalytic efficiency. In order to enact these transformations, many enzymes require some
non-protein cofactor, such as metal ions or metal clusters, such that approximately 1/3rd of
human proteins require some metal cofactor for full functionality.34
The functions of metalloenzymes range an impressive span of reactivity and are
responsible for catalyzing many of the indispensable processes in nature, such as
photosynthesis, water oxidation, nitrogen fixation, and respiration. Metals such as Fe and
Cu are well known for their roles as the prevailing redox metals, however there are many
examples of enzymes making use of other metals such as Mg, Zn, Ca, and Mo to enact
variegated chemical reactions (Figure 1.8)
For example, aerobic respiration is dependent upon the iron containing heme
proteins for the transport and storage of oxygen. Nitrogenases utilize a Fe/Mo ion cluster
with bridging sulfides to catalyze nitrogen fixation,35 and the oxygen-evolving complex of
photosystem II makes use of a MnCaO4 cluster to convert water into O2.36, 37

15

Figure 1.8 Natural metalloenzymes
These are key examples of metalloenzymes that catalyze thermodynamically
unfavorable reactions that are not only crucial for life, but are exceedingly difficult to
reenact outside of the enzymatic realm of chemistry.
1.1.1.2 Organometallic catalysis

16

Within the field of synthetic chemistry, transition metal catalysts have been utilized
to enact a range of chemical transformations, such as C–H functionalization, crosscoupling, and olefin metathesis. With a relatively large substrate scope, the challenge with
many of these small molecule homogenous catalysts has been dictating selectivity (regio-,
chemo-, or stereo-) of the reaction. This control has been afforded primarily by modulating
the primary coordination sphere; typically, the ligands that interact directly with both the
metal center and the substrate.38

Figure 1.9 Enzyme vs homogenous catalysis
In addition to producing catalysts that impose selectivity via the primary
coordination sphere, there have also been several examples of catalysts changing ligands
distal to the metal center, which is the secondary coordination sphere.39 This operates using
17

weaker non-covalent interactions, such as hydrogen bonding or steric interactions that
impose directionality and control, yet these systems require extensive engineering and are
typically limited to a small substrate scope.39, 40

Figure 1.10 Bioconjugation methods. a) Dative, b) covalent, c) supramolecular

1.1.1.3 Early artificial metalloenzymes

The first report of a protein being used as a scaffold for a non-native metal came
with Kaiser and Yamamura’s 1976 report of substituting the Zn (II) of carboxypeptidase
A (CPA) with a Cu (II) center.41 Initially a hydrolytic enzyme known to exhibit peptidase
and esterase activity, when the native metal center was removed via dialysis and replaced
with a Cu(II) ion all hydrolytic activity was lost but the ability to oxidize ascorbic acid to
dehydroascorbic acid was gained. While copper itself is a very common metal for natural
metalloenzymes, by substituting the metals they were able to confer the ability to catalyze
a different form of chemistry, albeit a known hydrogenation.
Shortly after that in 1978, Whitesides and Wilson utilized a completely different
approach by anchoring a Rh(diphosphine) within avidin.42 By using the high affinity of
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biotin for avidin, they were able to accomplish the asymmetric hydrogenation of several
substrates due to the inherent chiral environment (Figure 1.11).
1.1.1.4 Dative

Following these two initial results, there was a period where no further research
was considered regarding ArMs, most likely due to the difficulty exploring ArM variations
in comparison to the burgeoning growth of small molecule homogeneous catalysis.
Following the advent of recombinant protein expression and single point mutations
however, ArMs could be generated with modified residues and metallic handles installed.
Distefano and Davies exemplified this by covalently linking a 1,10-phenanthroline ligand
using an installed cysteine residue within the cavity of adipocyte lipid binding protein
(ALBP) to bind to Cu (II).43 With this system in place, the ArM could catalyze the
enantioselective hydrolysis of racemic esters.

19

Figure 1.11 Early artificial metalloenzymes; Kaiser and Whitesides

1.2.2 Artificial metalloenzyme assembly

Deliberately installing Lewis basic amino acids with which to coordinate some
unnatural metal is the least utilized method, most likely due to the large degree of
variability that comes with reorganizing the first coordination sphere. Despite that, there
have been several examples, such as Popp and Ball’s example of a peptide bound
dirhodium center through two installed glutamate residues (Figure 1.12).44

20

Figure 1.12 Popp and Ball’s artificial metallopeptides
More common is to utilize the naturally occurring binding site for a metal, and to
change out the naturally occurring metal for a different one. This is the strategy that was
utilized by the Kaiser group with carboxypeptidase A but has been most efficiently used
with carbonic anhydrase. The naturally occurring metalloenzyme catalyzes the hydration
of carbon dioxide and dehydration of bicarbonate within the vascular system, utilizing a
coordinating Zn (II) ion.45 The tri-histidine active site has proved labile to substitution to a
variety of different divalent metals, such that following the sequestration of zinc using 2,6pyridinedicarboxylate the Kazlauskas and Soumillion groups have installed both Mn (2)
and Rh (2) into the system.46-49
1.1.1.5 Covalent Anchoring

The third strategy is to covalently anchor the metal center to form a novel active
site, typically by modifying a biomolecular host, to which the metal catalyst can then be
attached via several methods. The first of this type of semi-synthetic enzymes was prepared
21

by Kaiser in which the sulfhydryl of Cys25 within the binding pocket of papain was
alkylated with different flavins, resulting in increased oxidoreductase activity towards Nbenzyl-1,4-dihydronicotinamide (Figure 1.13). A very similar strategy was utilized by de
Vries by decorating the Cys25 with a phosphorous ligand, which could then be complexed
with [Rh(COD)2]BF4, affecting a hydrogenation ArM 50, 51 (Figure 1.13). Salmain installed
a Ru (II) catalyst within the active site, creating a catalytic Diels-Alder ArM-papain.52

Figure 1.13 Covalent Anchoring strategies
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These methods utilize an already existing reduced cysteine residue which can be
easily decorated with different electrophilic linkers. This relies however on an accessible
cysteine residue, which often has some catalytic function within a binding site. Since the
catalytic function of ArMs do not need to depend on the original function of the protein
itself, other properties can then be prioritized, such as organic solvent tolerance or
thermostability.53 Cysteine residues for this purpose have been expressed in recombinant
proteins, such as in Distefano’s example above, with the major caveat that the reactive
residue is uniquely existent to achieve site-selective modification. Utilizing an installed
cysteine moiety within a protein scaffold is a common approach54-57, however disrupting
molecular function or folding makes the approach difficult in some proteins. Other, more
biorthogonal approaches have also been utilized, such as the use of strain promoted azidealkyne cycloaddition (SPAAC)58, 59 to generate dirhodium ArMs. Making use of prolyl
oligopeptidase (POP) containing a p-azido-L-phenylalanine, the Lewis group has been able
to enact asymmetric cyclopropanations using a dirhodium catalyst (Figure 1.14)
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Figure 1.14 Installing unique amino acids
This approach enables a greater variety of proteins to be explored, as azide
functionalities have been successfully integrated into a variety of proteins without
deleterious effects on form and function.
1.1.1.6 Supramolecular Anchoring

The final major strategy used to anchor a metal moiety within a biomolecular host
is supramolecular anchoring, in which a ligand or linker with a strong and specific
molecular recognition is attached to the metal center. A prime example of this is the
streptavidin/biotin system pioneered by Whitesides, a strategy that has been recapitulated
by Ward. Biotin has an unusually high affinity for streptavidin (Ka = 1015 M-1)60, and can
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easily be added to a wide variety of ligands. The inherently chiral environment of the biotin
binding pocket, referred to the vestibule, transfers chiral information naturally to a wide
variety of reactions.
The initial ArM catalyzed asymmetric hydrogenation reported by Whitesides
showed moderate enantiomeric excess,42 however the approach used by Ward focuses on
modulating both the primary and secondary coordination spheres, coined a chemogenetic
optimization strategy. The primary coordination sphere, consisting of the ligand and linker,
can be altered through standard chemical synthetic methods, and the secondary
coordination sphere by site-directed mutagenesis and directed evolution. With this strategy,
the Ward group has applied the SAV system to allylic alkylations,61 dihydroxylations,62
asymmetric hydrogenations, 63-67 and other reactions (Figure 1.15).68-75
While the biotin-(strept)avidin system has been utilized extensively by the Ward
group, there have been other supramolecular approaches explored. One unique approach is
provided by the Roelfes group, who took advantage of the hydrophobic cavity formed
between the dimer subunits of Lactococcal multidrug resistance regulator (LmrR).76, 77
Within this cavity they were able to implant a Cu(II) complex, relying upon two tryptophan
residues to form a π-stacking interaction with the phenanthroline ligand (Figure 1.16).
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Figure 1.15 Various examples of Ward's work embedding metals within
strept(avidin), with and without biotin conjugation
Within a buffered solution this was able to catalyze a Friedel-Crafts alkylation
between an indole and imidazole with decent enantioselectivity.77 Using the same system,
they then modified the area around the pivotal tryptophan residues, and were able to install
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a heme cofactor which could then catalyze the cyclopropanation of various styrenes with
mild enantioselectivity.78

Figure 1.16 Other supramolecular anchoring strategies

1.2.3 Artificial metalloenzymes within cellular systems
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Embedding a synthetic metal center within a protein lends several potential
advantages to the catalytic activity. Early examples capitalized on the induced chiral
environment to catalyze a variety of asymmetric reaction. Further examples take advantage
of that same environment to not only induce chirality, but to also exclude solvent from the
transition state and slow the rate of byproduct formation. Most early examples utilize only
the protein itself, such that following expression the protein was purified, and all
subsequent reactions took place within a buffer, usually with some organic cosolvent to
solubize the organic substrates. The full potential of ArMs however is realized when they
are utilized within the complex biological system of a living system. This however has
proven to be a not trivial task, since many metal cofactors are inhibited by cellular
components, the principle of which being glutathione.79, 80 Metal incorporation into the
cell, let alone to the correct scaffold, are all complicating factors.
Despite these challenges, there have been several examples that have successfully
generated ArMs within living systems. The first example of this was with Song and
Tezcan’s generation of an artificial metallo-β-lactamase, which when expressed within the
periplasm of E. coli enabled the bacteria to survive treatment with ampicillin.81 First
mutating cytochrome cb562 to form a self-assembling tetramer, then generating variants
with coordinating residues (His/Glu) such that catalytic Zn sites would be formed, an ArM
that could hydrolyze ampicillin was formed. Using a N-Terminal translocation sequence,
the ArM could mature within the periplasm of E. coli and granted mild ampicillin resistance
(0.8-1.1 mg/L).81
Using the biotin/streptavidin system, Jeschek and Ward generated a ruthenium
containing ArM which could catalyze ring closing metastasis (RCM) in vivo.79
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Biotinylating a Hoveyda-Grubbs 2nd generation catalyst, then incubating that with E. coli
expressing periplasmic streptavidin resulted in the formation of the active ArM localized
in the periplasm. By using the fluorescent molecule umbelliferone as their model substrate,
they could screen several thousand mutants in a few days, allowing them to use saturation
mutagenesis to develop a high activity RCM ArM. In subsequent studies, they have utilized
this method of secreting streptavidin into the periplasm to catalyze transfer hydrogenations
with an iridium catalyst.82
There have also been several reports of functional ArMs being expressed on the
surface of live cells, the majority of which utilize the same biotin/streptavidin system
described above. Heinisch and Ward expressed SAV with a Lpp/OmpA leader sequence,
which results in SAV secretion into the periplasm, followed by anchoring to the outer
membrane. Using a biotinylated ruthenium catalyst, they were afforded an artificial
deallylase, whose activity they could track using an uncaged fluorescent aminocoumarin.83
Surface expressed ArM’s haven’t just been achieved with E. coli, but with other organisms
as well. Utilizing the same deallylase catalyst described above,83 an electrophilic Nhydroxysuccinimide ester was used to anchor the ArM onto the cell wall of
Chlamydomonas reinhardtii.84 Finally, there is a singular report of ArM use within
mammalian cells. Okamoto and Ward used a cell-penetrating linker to pull both the
ruthenium and SAV into HEK-293T cells, where acting as a deallylase it uncaged
triiodothyronine (T3), a thyroid hormone that upregulated an installed gene switch.85
As previously mentioned, there is a very recent example that generated a
metalloenzyme that catalyzes the olefin metathesis between ethylene and a fluorescent
molecule. By doing this, the Tanaka group was able to increase the water solubility of the
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lipophilic complex, and additionally protected the precious metal catalyst from deleterious
water-soluble interactions, most notably glutathione and other small molecular weight
thiols. Using a three-component probe based on a Hoveyda-Grubbs catalyst (HGC), 7diethylaminocoumarin (DEAC), and 4-((4-(Dimethylamino)phenyl)azo)benzoic acid
(DABCYL) units (Figure 1.17).33
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Figure 1.17 Tanaka's example of an ethylene sensing artificial metalloenzyme
DEAC is the fluorescent molecule, and is appended to the mesityl backbone of the
HGC, on which the olefin component is decorated with the DABCYL moiety, which is
known to be a quencher for coumarin based dyes.86 Using this system, they were able to
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record down to 27 ppm for their LOD dissolved in THF, but more significantly were able
inject a metal based ethylene probe into the plant cellular environment.33
This was an elegant solution to place the ruthenium cofactor within the living
environment of the cell, and unlike many of the artificial metalloenzymes that have been
covered herein, there is no specific bioconjugation method used in the design of the probe.
Instead, the authors utilized albumin as their enzyme, which while bereft of a specific
binding site that could be used for supramolecular binding, does possess of a large
hydrophobic pocket in which the hydrophobic probe could localize.87 While this was
effective in sequestering the probe and protecting it from glutathione,33 this system requires
using isolated protein and probe to premix prior to any cellular usage, which greatly limits
the ability to use this system for in vivo. This is in contrast to Ward’s example of in vivo
metathesis, in which the biological scaffold (streptavidin) is expressed and stays within the
cell, and the metal cofactor with a bioconjugation linker (biotin) is added to the cells. This
two component system has the benefit of actual in vivo usage, an attractive goal for ethylene
detection.
While the Tanaka manuscript was published after the commencement of this thesis’s
primary project, the shortcomings of that probe serve to highlight what this project’s goals
were. Combining the known ability of the ruthenium probes BEP4 and BEP5 to detect and
quantify ethylene in a variety of environments, with recent advances presented by the Ward
group in in vivo transition metal chemistry, it was hoped to prepare an ethylene detecting
artificial metalloenzyme. Efforts towards that goal are presented herein.

1.3

Results and discussion:
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The Bio-BEP system with the N-Heterocyclic Carbene (NHC) bearing the biotin
linker has been shown to be the most efficacious system for olefin metathesis,79 so those
were the initial targets to synthesize. While significant effort does go into decorating the
ruthenium core of the probe, the primary synthetic hurdle was the synthesis of the biotinNHC conjugate. On the NHC itself, there are two unique sites that can be used for biotin
attachment, those two being on the mesityl group 70 or on the backbone of the heterocycle
71. It has been reported that the difference in the two sites results in a difference in catalytic
ability of the streptavidin/Ru conjugate by Ward,88 however since our goal is the singular
reaction of ethylene with the ruthenium to release the fluorophore, it was decided that both
attachment points were worthwhile to explore.
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Figure 1.18 a) Possible Bio-BEP’s and their biotinylation points and b) broad
retrosynthetic route to the mesityl substituted complex
The precursor to most metal-NHC complexes is an imidazolium salt, such as is
shown in 72. While the synthesis the Bio-BEP is novel, the synthesis of the imidazolium
precursor for the mesityl substitution has been reported by Ward, and so this route was first
attempted.

34

Reacting first mesidine with oxalyl chloride in a 1:2.2 ratio yields the acyl chloride
in a 53% yield (Figure 1.19). This is smoothly reacted with 4-Bromo-2,6-dimethylaniline
to yield diamide 73. The reduction of 73 to the diamine is a challenging reduction, requiring
rigorously degassed toluene and fresh borane dimethyl sulfide to accomplish the reaction
in reasonable yield. The detail about using degassed toluene was not known when this route
was first attempted, which resulted in many failed attempts to reduce the diamide.
Following alternative reaction screenings (see below), this route was eventually revisited,
and degassed solvent used, to afford 74 in 38% yield.

Figure 1.19 Ward’s original approach to the mesityl substituted NHC, with
averaged yields
Subsequent Rosenmund-von Braun reaction, reduction, and protection of the amine
were accomplished in yields similar to those reported by the Ward group to give 75.
Condensation of diamine to the imidazolium salt results in a difficult to purify salt, however
following extensive trial and error the NHC precursor 72 can be prepared in 90% yields.
The pivotal reduction was not optimized until several alternative routes were
attempted. A continual hinderance in the synthesis, even following the optimization of the
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dimethyl sulfide borane reduction, was the continual low yields achieved at the end of the
synthesis, such that even Ward’s reported yield after 7 steps was a 9% yield, an undesirable
amount considering its importance in later steps.

Figure 1.20 Direct amidation approach using ethyl chlorooxoacetate
Seeking to reduce the length of the synthesis and bypass difficult steps by using a
convergent approach, an amidation strategy was first explored, with 76 being generated
following reaction with ethyl chlorooxoacetate. In all instances no conversion to diamide
was observed, even with the inclusion of base or exploring different solvent systems. Due
to the sterically hindered amine of the mesityl group, regular amidation to 77a-c simply
wasn’t feasible on a useful timescale. Knowing that, activating the ester then attempted.
With ester 76 in hand, carboxylic acid 78 was easily accessed, and with modified
aryl amine 79a-c amide coupling using DCC proved moderately successful to give 80a and
80c. With a route to a more decorated diamide, further reduction steps were attempted, and
summarily failed to give 81a or 81c. Astringent conditions were required for borane
complexes to reduce diamides, and hydride species did not possess the required reactivity,
especially due to the potentially chelating ability of the diamide. In the case of the Boc
protected amine 80a loss of the Boc group was typically observed under both reductive
conditions, however no reduction of either amide was observed.
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Figure 1.21 Amide coupling strategy
In an attempt to circumvent the difficult diamide reduction entirely, the ethyl chain
of the backbone was installed using bromoethanol giving the amimoethanol. From here the
alcohol was converted into a more labile group with either an Appel reaction to install an
iodine in 83a-c, or simply mesylated with methanesulfonyl chloride to give 82a-c.
Disappointingly, all attempts to encourage the SN2 to failed to give 84a-c,
regardless of leaving group, solvent, base, or R-group identity. Following successive
failures in reducing the diamide, more intensive reduction protocols were researched, and
it was found that generating diborane in situ via NaBH4 and BF3*OEt2 had been efficacious
in reducing similar diamides.89 Additionally, diborane has been reported to reduce aryl
nitriles with ease, so it was hoped that reacting 85 would result in the triple reduction of
the diamide. Using thoroughly degassed THF, an almost complete reduction was observed
via NMR after 12 hours of reflux, which following separation yields an oil, which without
further purification can be protected using Boc anhydride to give 86.
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Figure 1.22 SN2 installation of imidazole backbone
Following optimization of the diamide reduction, a convergent approach was used
to synthesize the NHC precursor. Forming acyl chloride 87, which is reacted with aryl
nitrile 88 to form 89 in an 86% yield. Reduction and protection of the diamide gives 90 in
a high yielding reaction, which can be efficiently ran in a 10 mmol scale reaction.

Figure 1.23 in situ diborane reduction of diamide
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Figure 1.24 Modified convergent approach to mesityl substituted NHC
Condensation with neat triethyl orthoformate leads to the imidazolium salt 91,
which can be readily purified using iterative solvent-solvent recrystallizations. This
constitutes a 43% yield over 4 steps to the NHC precursor, as opposed to the 9% yield
accomplished using the reported methodology.

Figure 1.25 Generation of imidazole substituted NHC
The synthesis of the imidazole substituted NHC proved significantly more facile
than that of the mesityl substituted NHC. Allyl amine is first dibrominated, which can
undergo two subsequent substitutions when heated extensively in neat mesidine to give 92,
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albeit with significant aziridine based byproducts. The primary amine is Boc protected in
high yield, and the resulting white powder is condensed in neat triethyl orthoformate to
give the imidazolium salt 93.
With both of the imidazolium salts in hand, the next question became how to link
those onto the ruthenium metal. As shown in Figure 1.26, there are two general strategies
to append NHC’s both symmetrical and unsymmetrical onto a metal center, such as Ru.
The first and most common strategy is the use of a strong base, such as potassium tertbutoxide or potassium hexamethyldisilane (KHMDS), to generate the carbene in situ 95.
This can then readily undo go a ligand exchange with a tricyclohexyl phosphine to yield
the Grubbs two type complex 96.
Since the generation of the carbene often necessitates the use of a glove box, an
alternative route is the installation of an adduct of some form. The imidazolium salt 94 can
form adducts using chloroform, other metals such as silver and gold, or even with
carboxylates 97. The adducts are typically readily purified by chromatography, and can be
carried into the next reaction, in which the stronger NHC-Ru bond results in a ligand
displacement, and the subsequent formation of the Grubbs two type complex 96.
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Figure 1.26 General strategies to attach the NHC to the ruthenium center
Making use of a biotin for the bioconjugation of the NHC into a protein requires
the use of either streptavidin or avidin, both of which are comprised of 4 active monomers.
Both proteins have been used successfully by the Ward group, as well as others, however
the majority of these groups were not concerned with the potential problems of using a
tetrameric protein with fluorescent molecules. To that end, we turned to using a monomeric
form of streptavidin (MSA), which had been minimally mutated to prevent the monomers
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from associating together while maintaining the characteristically high binding affinity for
biotin.

Figure 1.27 MSA for biotinylated probe use, with possible experiments
Developed by Sheldon Park,90 the gene is commercially available through
KeraFast. As such, the target gene was first amplified from pRSET-MSA and periplasmic
tag pelB added using PCR, then digested with NdeI and XhoI and ligated into target vector
pET23a(+). Following the purification of pET23a-MSA2, the plasmid was transformed
into competent cell lines (β-10, BL21,T7-Xp). Following induction with isopropyl β-d-1thiogalactopyranoside (IPTG) however, no viable protein was observed on SDS-PAGE
following purification. This lack of expression resulted in screening several vectors
(pET24, pET24a, pET21, pET28a) in several competent cell lines (BL21, BL21-pLysE,
T7-XP).
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Following several iterations of plasmid construction without apparent protein
production, an alternative approach using a different periplasmic tag was approached. The
OmpA leader sequence has been reported to work efficacious within similar systems, so
that route was explored next. Due to the small size of the monomeric streptavidin,
combined with the necessity of appending both a HIS tag and an OmpA leader to the
sequence, it was decided that the entire insert would be generated by assembly PCR. Using
primers 1-5 the gene was assembled containing a C-terminus OmpA sequence and a Nterminal HIS tag.
Primer

GCTAGCATGACTGGTGGACAGCAAATGGGTATGGATGCGGAGGCG

1
Primer

CTGGTTTCGCTACCGTAGCGCAGGCCATGGCTAGCATGACTGGT

2
Primer

AAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGTTTCGCTACC

3
Primer

GGCGCACATATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTG

4
Primer

GGGCGCTCGAGTTTCACCTTGGTAAAGGTATCTTGGCCCTGTTC

5

Following confirmation of insert weight by agarose gel, the insert was then ligated
into pET21, pET24, and pET28 vectors, each of which was subsequently transformed into
BL21-pLysE and T7 express bacteria. Each vector/cell combination was then used to
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inoculate 1L of LB containing the appropriate antibiotic, which was then induced with
IPTG when the OD600 was 0.6-0.9. Cells were harvested after 12 hours of shaking at 18˚C,
and the cell pellet was sonicated, centrifuged, and the lysate was loaded onto a Ni-NTA
His-Trap column. The column was washed with buffered 20 mM imidazole, and the protein
was eluted with 200 mM imidazole. The fractions were analyzed by SDS-PAGE, by which
it was observed that the pET24a-BL21-pLysE system produced a protein of the correct
weight. This was collected and frozen without further purification.

1.4

Conclusions and future work

Two NHC’s bearing biotin have been successfully made, as have their precursors
for further reactions. These biotinylated NHC’s will be appended onto a Grubbs 1 catalyst,
from which point it should be facile to attach the styrene BODIPY, forming the HoveydaGrubbs type probe. With two handles in different locations, the probe itself will be in
different environments within the protein scaffold. On route to those NHCs, several
significant problems were encountered and overcome, most appreciably with the discovery
of the triple reduction using in situ diborane. This constitutes a significant improvement to
the synthesis of unsymmetrical NHCs, since that is one of the methods by which chiral
environments may be imposed upon a metal center.
Progress was also made in the production of the protein to be the scaffold of the
probe, monomeric streptavidin. A unique periplasmic export tag was appended using
assembly PCR, and initial results look promising for the expression of the protein. If
correctly being formed, the protein can be easily purified by conventional methods, and
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utilized for further experimentation with biotinylated probes. With this technology in hand,
the in vivo characterization of ethylene and its pathways can be further elucidated.

1.5

Experimental

2-(mesitylamino)-2-oxoacetyl chloride:

To a chilled solution of dry toluene (450 mL) was added oxalyl chloride (23.2 mL, 270
mmol, 2.7 eq.). A solution of 2,4,6-Trimethylaniline (14 mL, 100 mmol, 1 eq.) in toluene
(150 mL) was added dropwise via cannula over a period of 80 minutes. The solution was
stirred for 2 hours at 0˚C, following which the solution was filtered through a Buchner
funnel, and the filtrate volatiles removed in vacuo (caution: oxalyl chloride readily pulled
off). This crude material was triturated with petroleum ether, and the precipitate collected
to yield a hygroscopic white fluffy solid. (Yield 50%, 11.1g) The spectrum matches
previously reported spectrum.
1

H NMR (500 MHz, CDCl3) δ 7.98 (s, 1H), 6.96 (s, 2H), 2.32 (s, 3H), 2.22 (s, 6H).

4-amino-3,5-dimethylbenzonitrile

4-bromo-2,6-dimethylaniline (20.0 g, 100 mmol, 1 eq.) and copper(I) cyanide (19.7g, 220
mmol, 2.2 eq.) were suspended in NMP (260 mL) and heated to 160˚C for 18 hours. After
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cooling to room temperature, the reaction was quenched with the addition of a 1:1 solution
of NH3:H2O (30 mL) and stirred for 30 minutes. This was filtered through a Celite plug
and extracted with EtOAc (3x) and the organic layers were washed extensively with brine.
For <20 mmol scale reactions, simple chromatography (DCM) affords product as a light
pink solid. For 20mmol> reactions bulb to bulb distillation was found to be the most
effective purification method, yielding product as a light pink solid. (Yield 67% and 35%)
The spectrum matches previously reported spectrum.
1

H NMR (500 MHz, CDCl3) δ 7.17 (s, 2H), 4.19 (s, 2H), 2.15 (s, 6H).

13

C NMR (126 MHz, CDCl3) δ 147.48, 132.05, 132.03, 121.47, 121.46, 120.77, 98.94,

17.32.
N1-(4-cyano-2,6-dimethylphenyl)-N2-mesityloxalamide

The acyl chloride (8.42 g, 37 mmol, 1 eq.) was dissolved in dry DCM (120 mL), and cooled
to 0˚C. In a separate flask, the nitrile (5.42 g, 37 mmol, 1 eq.), triethylamine (5.2 mL, 37
mmol, 1 eq.), and DCM (35mL) were combined, and added to acyl chloride over 30
minutes, then the reaction mixture stirred at room temperature overnight. Et2O is added to
the reaction mixture, and the resulting solid collected. The precipitate was washed several
times with Et2O and 1
M HCl, then dried to afford the product as an off white solid. (Yield 73%)
1

H NMR

13

C NMR
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N1-(4-(aminomethyl)-2,6-dimethylphenyl)-N2-mesitylethane-1,2-diamine

Diamide (6.71 g, 20 mmol, 1 eq.) and NaBH4 (4.54 g, 100 mmol, 6 eq.) were added to a
flame-dried round bottom flask equipped with similarly dried condenser and charged under
N2. Thoroughly degassed dry THF (100 mL) was added and the reaction cooled to 0˚C.
BF3*OEt2 (21 mL, 160 mL, 8 eq.) was added dropwise, then following the violent
evolution of gas the reaction was brought to reflux for 36 hours. The reaction was quenched
by the addition of 4:1 MeOH/HCl (35 mL) at 0˚C, then the reaction mixture was evaporated
to dryness. The residue was then resuspended in 1 M NaOH and extracted with Et2O. The
organics were washed with water, then brine, and dried with Na2SO4. Evaporation of
solvent yielded a viscous light-yellow oil, which can be used without further purification.
The spectrum matches previously reported spectrum.
1

H NMR (500 MHz, CDCl3) δ 6.97 (s, 2H), 6.86 (s, 2H), 3.76 (s, 2H), 3.24 – 3.14 (m, 4H),

2.33 (s, 6H), 2.30 (s, 6H), 2.26 (s, 3H), 1.75 – 1.56 (m, 2H).
tert-butyl 4-((2-(mesitylamino)ethyl)amino)-3,5-dimethylbenzylcarbamate

Diamine (6.23 g, 20 mmol, 1 eq.) was dissolved in dry degassed DCM (12 mL), then cooled
to 0˚C. Boc2O (4.36 g, 20 mmol, 1 eq.) and DMAP (244 mg, 2 mmol, 0.1 eq.) were added,
then the reaction was allowed to warm to room temperature over 3 hours. The reaction was
extracted with DCM, washed with water, then dried with Na2SO4. The crude product was
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concentrated onto silica and purified by chromatography on silica gel to afford the product
as a viscous dark yellow oil. (44% over 2 steps). The spectrum matches previously reported
spectrum.
1

H NMR (500 MHz, CDCl3) δ 6.94 (s, 2H), 6.86 (s, 2H), 4.75 (s, 1H), 4.21 (d, J = 5.8 Hz,

2H), 3.24 – 3.13 (m, 4H), 2.32 (s, 6H), 2.30 (s, 6H), 2.26 (s, 3H), 1.49 (s, 9H).
1-(4-(((tert-butoxycarbonyl)amino)methyl)-2,6-dimethylphenyl)-3-mesityl-4,5dihydro-1H-imidazol-3-ium chloride

Into a round bottom flask equipped with a condenser was combined diamine (2.6 g, 6.32
mmol, 1 eq.), degassed triethyl orthoformate (21 mL, 126 mmol, 20 eq.), and anhydrous
NH4Cl (350 mg, 6.31 mmol, 1 eq.) were combined. This was heated to 120˚C for 16 hours,
after which the majority of the volatiles were removed by vacuum distillation. The resulting
gummy solid was triturated sequentially with EtOAc (3x), Et2O (3x) and Pet. Ether (3x),
following which no further color was observed to be removed by solvent. The sticky solid
was then dried on high vac with occasional passes of a flame (the compound is very solvent
sticky). This yielded a crunchy bubbly solid which was easily powdered with a glass stir
rod and was pure product. (Yield 74%) The spectrum matches previously reported
spectrum.
1

H NMR (500 MHz, CDCl3) δ 9.63 (s, 1H), 7.10 (s, 2H), 7.00 (s, 2H), 5.06 (s, 1H), 4.60

(s, 4H), 4.27 (d, J = 6.2 Hz, 2H), 2.47 (s, 6H), 2.44 (s, 6H), 2.32 (s, 3H), 1.48 (s, 9H).
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13

C NMR (126 MHz, CDCl3) δ 160.25, 156.06, 141.56, 140.41, 135.61, 134.96, 131.75,

130.27, 129.98, 129.93, 128.04, 79.58, 51.88, 51.76, 43.79, 28.37, 21.04, 18.19, 18.02.
2,3-dibromopropan-1-aminium bromide

Allyl amine (4.5 mL, 60 mmol, 1 eq.) was added into Di H2O (18 mL) at 0˚C, then HBr
(5.1 M sln in acetic acid, 13 mL, 66 mmol, 1.1 eq) was added dropwise. Br2 (4.6 mL, 90
mmol, 1.5 eq.) in DI H2O (18 mL) was added dropwise. This was stirred for 4 hours, during
which the ice bath was allowed to warm to room temperature. The solvent was removed in
vacuo, and the red solid triturated with ice cold methanol. The white crystals were collected
and washed minimally with methanol. The red filtrate was concentrated, and the red
crystals triturated with cold methanol to yield the white crystals, a process that was repeated
several times to yield the white crystalline product. (Yield 68%) The spectrum matches
previously reported spectrum.
1

H NMR (500 MHz, D2O) δ 4.53 (td, J = 9.5, 8.8, 4.1 Hz, 1H), 3.98 (dd, J = 11.0, 4.4 Hz,

1H), 3.80 (dd, J = 10.8, 9.0 Hz, 1H), 3.74 (dd, J = 14.1, 2.8 Hz, 1H), 3.39 (dd, J = 14.1,
9.6 Hz, 1H).
13

C NMR (126 MHz, D2O) δ 46.51, 44.32, 33.20.

N1,N2-dimesitylpropane-1,2,3-triamine
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Dibromide salt (10 g, 33 mmol, 1 eq.) was charged in a round bottom flask under N2, then
mesidine (60 mL, 440 mmol, 13 eq.) was added. The solution was stirred for 16 hours at
120˚C, and then was cooled to room temperature. Much of the mesidine was then removed
by distillation in vacuo at 85˚C, and the dark brown residue was dissolved in Et2O. This
was washed with 2 M NaOH, then H2O and brine, and subsequently dried with Na2SO4.
Following concentration the viscous brown oil was taken to a silica gel column, where the
remaining mesidine was eluted with 40% EtOAc/Hex, then the product was eluted with
10% MeOH/DCM, yielding a dark brown oil. (Yield 15%) The spectrum matches
previously reported spectrum.
tert-butyl (2,3-bis(mesitylamino)propyl)carbamate

Triamine (1.37 g, 4.2 mmol, 1 eq.) was dissolved in degassed DCM (10 mL) and cooled to
0˚C. To this was added Boc2O (0.918 g, 4.2 mmol, 1 eq.) and DMAP (5 mg, 0.4 mmol, 0.1
eq). This was stirred for 1 hour at 0˚C, and brought to room temperature over 2 hours.
Following the indication of starting material consumption by TLC, the reaction mixture
was washed with H2O and brine, then dried with Na2SO4. The product was obtained as a
white powder following purification by chromatography (10% EtOAc/Hex). The spectrum
matches previously reported spectrum.
5-(((tert-butoxycarbonyl)amino)methyl)-1,3-dimesityl-4,5-dihydro-1H-imidazol-3ium chloride
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Triamine (1.63 g, 3.8 mmol, 1 eq.) was placed in a round bottom flask equipped with reflux
condenser, then newly sparged triethyl orthoformate (9.6 mL, 57.5 mmol, 15 eq.) was
added. NH4Cl (215 mg, 4 mmol, 1.05 eq.) was added, then the reaction set to 120˚C for
16h. After cooling to r.t, most of the triethyl orthoformate was removed by either simple
distillation or simply in vacuo. The resulting orange gummy solid was triturated with Et2O
and the precipitate collected via vacuum filtration. This was washed several times to yield
the imidazolium chloride as a fine white/grey powder. The spectrum matches previously
reported spectrum.
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2. SYNTHESIS OF MYCOFACTOCIN
2.1

Introduction

2.1.1 Natural products

Natural products make up a massive breadth of the small molecules that are known
to be biologically active. The importance of these compounds are wide reaching, as is
highlighted by the significant roles of natural products in cancer and infectious disease
treatments, among many others. In addition, the unique frameworks that make the
compounds efficacious serve as a platform for further drug discovery. Indeed, roughly 47%
of small molecule chemotherapeutics are direct natural products, and 26% are derivates of
natural products.91 This in comparison to the single de novo drug approved for similar
usage (as of 2007) paints the utility of natural products with stark contrast.
The biosynthetic pathways that lead to these compounds lead to several different
classes, the four most pertinent being terpenoids, alkaloids, polyketides, and non-ribosomal
peptides.
The terpenoid class makes used of either isopentyl diphosphate and dimethylallyl
diphosphate as starting materials, however from those two simple starting materials
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originates drugs such as paclitaxel (Taxol) 1 and eleutherobin 2 (Figure 2.1).92 For scale,
over 55,000 different terpenes have been isolated acting in diverse functional roles.93

Figure 2.1 Examples of terpenoid natural products
Alternatively, the alkaloid class uses a wide scheme of different building blocks to
achieve the complicated structures that characterize the class. Since many of the alkaloids
are derived from amino acids, they have access to the many chemical moieties that
comprise the natural pool. Key to their structure is the presence of a nitrogen atom,
typically within some heterocyclic system.94 This can be observed just by the classes that
alkaloids are divided into, which are indoles, quinolines, isoquinolines, pyrrolidines,
pyridines, pyrrolizidines, and tropanes to name the most prominent.95 The diversity within
the structures is predictably echoed by a diversity in physiological effects: psychotropic,
anesthetic, analgesic, antimitotic, antibacterial, anti-inflammatory, and antitumor among
many others have all been observed.96 Well known alkaloids include caffeine 4, nicotine
3, and morphine 5 (Figure 2.2), among many others.97, 98
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Figure 2.2 Well known alkaloids
While these two classes are far from the only sources of natural products, they serve
to illustrate the breadth of chemical ingenuity that biosynthetic pathways have evolved.
While the four major classes are classically recognized, other biosynthetic routes that have
been highlighted by the advance of genomic technology, such as ribosomally synthesized
and post-translationally modified peptides.

2.1.2 Ribosomally synthesized and post-translationally modified peptides
(RiPPs)

Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a
recently discovered and growing class of natural products. The synthesis of many RiPPs
must begin with the translation of the gene cluster, producing not only the precursor peptide
but also the dedicated post translational modifying enzymes. On the precursor peptide
itself, there is often a leader sequence located on the N-terminus of the peptide, followed
by a core region on which the majority of the associated modifying enzymes will act
54

upon.99 The leader sequence serves as a recognition element, and is generally
proteolytically cleaved off at some point during the RiPP synthesis.100 (Figure 2.3).

Figure 2.3: Generalized RiPP biosynthetic pathway
There are upwards of 20 different classes of RiPPs, with most of the classes
delineated by the structural features of the product, as well as the biosynthetic
manipulations used to achieve that product.100 Classes include Lanthipeptides, linaridins,
thiopeptides, phallotoxins, and sactipeptides, among many others.100, 101 Representative
members from some of these families are shown in Figure 2.4, however for the purpose of
this dissertation no further exploration into those families is warranted. From these
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representative molecules it can be observed that not only are they quite large in comparison
to other natural products, but most retain their peptide bonds, reminiscent of their peptide
origin. There are several RiPPs that don’t follow those broad observations, being quite
small and lacking peptide bonds. It is this class and its representative members that shall
be discussed further.
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Figure 2.4 Representative RiPPs
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There are only a few of these small molecule RiPPs, such they consist of their own
class, rather than being subdivided into structural features or machinery as other classes
are. Major representatives of this class are pantocin A, the thyroid hormones T3 and T4,
and pyrroloquinoline quinone (PQQ). Pantocin A is an inhibitor of L-histidinol phosphate
aminotransferases in Pantoea agglomerans, and is comprised a modified tripeptide core
(Figure 2.5).

Figure 2.5 Proposed biosynthetic pathway of Pantocin A
Originating from a 30-residue precursor peptide, the Glu-Glu-Asn motif is
expressed along with three ORFs.102 The paaA gene catalyzes the double dehydration and
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decarboxylation of the adjacent glutamate residues, and the paaB gene encodes a Fe
containing oxygenase, serving to catalyze the final dehydrogenation to 13.103 The final
ORF, paaC is speculated to encode for a transmembrane efflux pump.102, 103 Following
action by peptidases the functional molecule is released and exported, where it acts to
inhibit enteric bacteria, particularly in nutrient deprived conditions.
One of the major small molecule RiPPs characterized to date is pyrroloquinoline
quinone (PQQ). Serving as a small molecule redox cofactor within a variety of Gramnegative bacteria, it can be utilized within a non-glycolytic ATP producing pathway.104 In
contrast to other RiPPs known to serve as redox cofactors, PQQ is synthesized as a discrete
molecule from precursor peptide PqqA. Within the PQQ gene cluster itself, there are 5
strictly conserved genes that serve to modify the glutamate and tyrosine side chains that
form PQQ. The gene cluster is annotated as pqqABCDEF/G, where pqqA encodes the short
(20-30 AA) precursor peptide (Figure 2.6). pqqB and pqqC encode for hydrolases and
oxidases respectively, pqqD is the recognition element, pqqE encodes for the radical SAM
enzyme PqqE, and PqqF/G is a peptidase.105
Following translation, PqqD acts to bring the glutamate and tyrosine residues into
proximity along with PqqE. The SAM catalyzes the C-C bond formation between the ortho
position of the phenol ring and the glutamate residue though radical proton abstraction.106
The peptidases PqqF/G then cleave the remaining residues of the precursor peptide, leaving
the two linked amino acids as a discrete molecule.106, 107 The tyrosine ring is oxidized by
PqqB, leading to a ring closing event to form AHQQ.108 This molecule is then acted upon
by PqqC to facilitate another ring closing event and the oxidation of the fused ring systems
to form PQQ.109, 110
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Figure 2.6 Proposed biosynthetic pathway of PQQ
With the over 1000 bacterial genomes111 characterized, there have been several
lucrative attempts to highlight novel biological systems through bioinformatic studies.
Since RiPPs are often characterized by the conserved arrangement of their posttranslational proteins, the pathways can sometimes be predicted from sequencing data. This
is especially powerful considering that many RiPPs are synthesized in response to some
environmental trigger, the isolation of such a novel product falling to chance or exhaustive
screening efforts. Bioinformatic studies and genome mining studies have led to the
discovery of novel pathways that otherwise would have been remained hidden.101, 112, 113
One such study, using a radical SAM system similar to the one found in the biosynthesis
of PQQ as a focus point found a well conserved C-terminal motif which could feasibly be
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a RiPP.114 This gene cluster has since been found to produce a small molecule that has been
titled mycofactocin (MFT).

2.1.3 Mycofactocin

Even though the gene cluster is found in over 600 unique species115, the exact
molecular function of MFT is yet unknown, but there are several possible functions that
have been implicated. The same study that identified the MFT cluster also proposed that
MFT could participate as a redox cofactor, since it was found that several redox active
genes are dependent upon the pathway.114 This was corroborated by the finding that MFTassociated dehydrogenases with a bound NADH did not allow the diffusion or turnover of
the nicotinamide cofactor, not until the inclusion of a strong non-natural redox mediator
2,6-dichlorophenolindophenol (DCPIP), which indicates that MFT could be acting as a
redox mediator within the natural environment of the dehydrogenase.116
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Figure 2.7 Proposed biosynthetic pathway of Mycofactocin
The biosynthetic pathway of MFT consists of a 6 gene cluster, labeled as
mftABCDEF, representing the precursor peptide along with the possible posttranslationally modifying enzymes (Figure 2.7). MftA is the 31 amino acid precursor
peptide, and MftB is thought to contain the recognition element, which binds and directs
MftA. MftC catalyzes first the SAM-dependent oxidative decarboxylation, and then a
subsequent SAM-dependent 5-exo-trig cyclization to form lactam MftA*.117-119 MftE
hydrolyzes the lactam in an iron dependent fashion, leaving the free molecule AHDP.120
This is then acted upon by MftD, which catalyzes the oxygen dependent deamination of
ADHP to form premycofactocin (PMFT) (Figure 2.8). This α-ketoamide forms the redox
center that was originally hypothesized, with a 2e-/2H+ mechanism and an E1/2 = -255mV,
forming PMFH2.121
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Figure 2.8 Function of MftF, and possible structures of MFT
The final enzyme, MftF, has a yet unclarified function within the biosynthesis of
MFT. Initially hypothesized to act as a glycosyltransferase,122 a single study using
metabolomics has identified oligioglycosides with a mass difference that corresponds to
PMFT.123 They hypothesized that MftF decorated the phenolic alcohol of PMFT with β1,4-glucan chains, leaving the redox active α-keto amide moiety in place.123 This was not
done with purified MftF however, and it is likely that glycosylation isn’t the only story of
MFT. The transmembrane domain of MftF and biologically relevant redox potential hint
to a possible function in metabolism, however this will have to be address in further studies.
It has been found that the redox homeostasis of M. smegmatis is reliant upon the
expression of the MFT gene cluster, as well as the ability to acclimate to alternative carbon
sources, such as small chain alcohols or cholesterol.124-126 This indicates that the MFT
genes, and presumably its product, are important for the survival of M. tuberculosis. As a
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pathway that produces a small molecule, there are opportunities to pursue MFT analogues
as inhibitors of the pathway, which is especially pertinent considering the possible role of
MFT in the virulence of M. tuberculosis.
The isolation of PMFT was pivotal in proving the role of MftD, as it allowed for
not only the assigning of mass spectrum data, but also allowed for structural assignment
based on 1H NMR, 13C NMR, COSY, HMBC, and HSQC data. This isolation of PMFT
was an involved process, requiring several liters of growth media in conjunction to using a
synthetic MftA with a 13C labeled valine and tyrosine, which was used through reactions
with MftB, MftC, MftE, MftD, leading to a completely 13C labeled PMFT. This effort was
necessary to simply obtain the resolution required for a

13

C experiment. Further studies

using PMFT or PMFH2 necessitated a synthetic route, one that allowed for appreciable
yields while also granting access to possible analogs. The focus of this chapter is the
synthesis of PMFT and PMFH2.

2.2

Synthesis of PMFT

2.2.1 Previous attempt
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Figure 2.9 Previous attempt to PMFT
The synthesis was first attempted by Dr. Richard S. Ayikpoe of the Latham lab,
who first accessed the nitroethyl benzene with a Knoevenagel condensation with pmethoxy benzaldehyde and nitroethane in high yield. This was followed with a facile
reduction of the alkene with NaBH4 to give the unsaturated nitroethyl. The β-addition to
the acrylate was achieved in a 30% yield, then the resulting ester was reduced using zinc
dust with concentrated HCl. Upon reduction to the amine, the proximity of the nearby ester,
aided by the Thorpe-Ingold effect, quickly induced cyclization to form the lactam in decent
yield. The amide was smoothly protected in a 65% yield. The next challenge was the
installation of the α-hydroxy group. Bis(trimethylsilyl)peroxide has been used to install αhydroxy groups,127 so this route was first explored. The enolate was generated using LDA,
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and silyl peroxide added. This yielded a complex mixture of compounds, which following
successive failures to purify led to simply trying to oxidize the presumed alcohol. The
oxidation however failed, reacting significantly with the benzylic position to yield
carboxylic acids. It was at this point that this project was resumed by the author.

2.2.2 Synthesis of Mycofactocin

Since both the reactions leading up to the nitroethyl benzene were high yielding, no
attempt was made to further increase the yield. However, the subsequent β-addition
required some optimization as it was early within the synthetic steps. It was known that the
use of a long chain tetra-alkyl ammonium salt as a phase-transfer catalyst aided the speed
of the reaction, since under normal conditions the rate of addition would be exceedingly
slow. Following the reported conditions of 1:1 nucleophile: electrophile with one
equivalent of TBAF in THF gave decent conversion (30%) after 48 h at 40˚C. In an attempt
to increase the yield, several variations of the reaction were explored, such as increasing
the temperature, including a non-nucleophilic base, or increasing the molar equivalents of
the ester. None of these variations seemed to increase conversion, as monitored by NMR.
Indeed, after observing a 30% conversion after 48 hours, then a 55% conversion at 72 hours
from the same reaction, it was concluded that time was the largest consideration.
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Figure 2.10 β-addition screening
It was hoped that with the reduction of the nitro group to a nucleophilic amine, the
proximity of the ester would lead to the formation of a 5 membered lactam. The 2 methyl
groups would aid in the rapidity of the reaction as well, given the Thorpe-Ingald effect
sterically influencing the carbonyl carbon towards the nascent amine. With that goal in
mind, several options of reducing agents were reviewed. Wanting to avoid reducing agents
that could deleteriously react with an amide, LiAlH4 was discarded. NaBH4 alone likely
wouldn’t be able to reduce the nitro group without the addition of some Lewis acid, or
converting it into a more potent hydride species (LiBH4) or into diborane as was done in
the previous chapter. Reviewing the literature and available chemicals, more classical
reductions such as Zn/HCl, Pt/C, and Raney Nickel were attempted. While the use of Zn0
and concentrated HCl was a route that was purported to achieve the necessary reduction,128
attempts to recreate that success were summarily met with failure and the production of an
excess of side products. Both palladium on carbon and Raney Nickel were then attempted
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with a balloon of hydrogen gas, however no conversion was observed and starting material
recovered.

Figure 2.11 Hydrogenation attempts and Parr Bomb conditions
In a happy discovery, a hitherto unknown piece of equipment in the lab was
revealed to be a Parr bomb, a specialized piece of laboratory equipment that is designed
for reactions that need to be run under high pressure, temperature, or both. In the light of
this discovery, a compressed gas cylinder of H2 was used to pressurize the bomb containing
Raney Nickel and the ester in absolute methanol to 60 psi (~4 atm) and heated to 65˚C in
a sand bath for 12 hours. The crude NMR showed an almost complete conversion of the
ester to the lactam hoped for. Knowing that the following steps would be intolerant of the
amide proton, the nitrogen was then protected with a tert-butyloxycarbonyl group (Boc)
succinctly.
After conducting a thorough literature search, several options were considered
viable for installing the α-hydroxy moiety, the three likeliest candidates being oxaziridines,
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molecular

oxygen,

and

oxodiperoxymolybdenum(pyridine)-(hexamethylphosphoric

triamide) (MoOPH), in order of gauged success. Each of the reagents acts as an
electrophilic source of oxygen, meaning that each of the reactions would require forming
the enolate from the lactam. Since it was judged to be the most likely to succeed, the first
to be attempted was the use of an oxaziridine, namely Davis’ sulfonyloxaziridine.

Figure 2.12 Possible α-hydroxylation reagents, and attempted conditions
Gratifyingly, Davis’s reagent appeared to work on the first attempt, and the αhydroxy amide was purified in a 30% yield, a result that has since been difficult to
recapitulate, which is discussed in further detail further in the chapter. Having isolated the
alcohol, the final step to PMFTH2 was the removal of the methoxy and Boc protecting
groups. For this a traditional approach with BBr3 was used, and was adequate in removing
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both protecting group in a matter of hours at 0˚C. 1H, 13C, and 2D experiments were used
to verify the product, which was further confirmed by the exact HRMS mass.
With this success in hand, the synthesis was reattempted in order to build up further
stock and to attempt further reactions, such as the oxidation of PMFTH2 to PMFT, forming
the α-ketoamide. To this end, starting material was synthesized and accumulated up to the
Boc protected amide. From this point however, there were difficulties in recapturing the
initial success of installing the α-hydroxy moiety.

Figure 2.13 Modified completed route to MFT
The first issue was the purification of the product from the byproducts formed as a
result of using Davis’s reagent, namely sulfonamides and imines. Successive columns and
attempted recrystallizations summarily resulted in a loss of product. In addition to this,
starting material was continuously recovered in ever greater amounts. In order to address
this issue, several different amide bases were screened, such as LDA, LiEt2N, LiTMP,
LiHMDS, and KHMDS. The THF was used was further dried, and it was ensured that all
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reagents being utilized were purified. Observing a continuation in the trend lead to the
conclusion that the Davis’s reagent had simply decomposed over time, which led to
screening other possible reagents to install the alcohol.

71

Figure 2.14 Proton and Carbon NMR of PMFT
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First attempted was the use of molecular oxygen, as that had been successfully used
by other groups with similar substrates,129,

130

however this showed no observable

conversion of starting material into either the alcohol or hydroperoxide. A slightly different
oxaziridine was then explored, based on camphorsulfonic acid as opposed to tosic acid.
This reagent has found much use as a reagent for asymmetric hydroxylation, however is
also known to be more bench stable and usable than its tosic acid analogue.131 With this in
hand, there has been some initial success in installing the alcohol, as determined by NMR.

2.3

Future directions

With a route now available to PMFTH2, there are several options that can be further
explored. Firstly, is to explore oxidation methods to yield PMFT. For this, it is anticipated
that traditional oxidation methods that selectively react with alcohols over benzylic protons
will succeed, such as a Swern Oxidation132 or Dess-Martin periodinane, among others.
Following this optimization, analogs of PMFT and PMFTH2 can be synthesized in order
to probe MFT’s molecular function and possible therapeutic uses. Examples of these
analogues are shown in Figure 2.15.
While there is more synthetic work required to access PMFT and MFT itself,
having elucidated a synthetic route to PMFTH2 grants access to those molecules, in
addition to a variety of yet untested analogues. As a novel RiPP with unexplored
significance within M. tuberculosis, synthetic MFT will be a tool to leverage more
information concerning one of the world’s deadliest diseases.
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Figure 2.15 Possible oxidation strategies to yield the α-diketone, and other analogues
for PMFT

2.4

Experimental

(E)-1-methoxy-4-(2-nitrovinyl)benzene (1): To a mixture of 4-methoxybenzaldehyde
(15 g, 110 mmol, 1 eq.) in 200 ml of methanol was added nitromethane (5.9 ml, 110 mmol,
1.0 eq.) and the reaction was mixture was cooled to -10 oC. NaOH (5.28 g, 145 mmol, 1.2
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eq.) was added slowly into the reaction mixture through an addition funnel. The reaction
mixture was stirred at this temperature for 1.5 h. Upon completion monitored by TLC, the
mixture was neutralized with 4 M HCl to form a yellow precipitate. The precipitate was
filtered and dried to afford the desired product as a yellow solid, yield 96% (19g).
1

H NMR (500 MHz, CDCl3) δ8.01 (d, J = 13.6 Hz, 1H), 7.58 – 7.51 (m, 3H), 6.98 (d, J =

8.9 Hz, 2H), 3.90 (s, 3H).
13

C NMR (126 MHz, CDCl3) δ162.96, 139.08, 135.05, 131.20, 122.57, 114.95, 55.56.

1-methoxy-4-(2-nitroethyl)benzene (2): 1 (14.9 g, 83 mmol, 1 eq.) was added to a stirred
suspension of silica (150 g, 60 Å, 230-400 mesh, Silicyle) in a mixture of chloroform (200
mL) and isopropyl alcohol (60 ml) at 25 oC. The resulting yellow mixture was cooled to 0
o

C, and sodium borohydride (6.9g, 182.6 mmol, 2.2 eq.) was added slowly over 30 min.

The resulting mixture was then stirred vigorously at this temperature for additional 30 min.
The mixture was allowed to warm to 25 oC and allowed to stir at this temperature for 30
additional min. The suspension was cooled to 0 oC and aqueous solution of hydrochloric
acid (0.2 M) was added slowly until no gas evolution was observed. The resulting mixture
was filtered, and the residue was washed with dichloromethane (150 ml). The filtrate was
washed with water (200 ml), the aqueous phase was extracted with dichloromethane (3 x
50 ml) and the organic phases were pooled together, washed with brine (2 x 50 ml), and
dried over anhydrous sodium sulfate. The dried solution was filtered and concentrated
under vacuum to afford the desired product as a reddish oil, yield 94% (14.2 g).
1

H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 8.6 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 4.60 (t, J

= 7.4 Hz, 2H), 3.81 (s, 3H), 3.28 (t, J = 7.4 Hz, 2H).
13

C NMR (126 MHz, CDCl3) δ 158.89, 129.66, 127.64, 114.33, 76.61, 55.27, 32.68
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5-(4-methoxybenzyl)-4,4-dimethylpyrrolidin-2-one (3):

To a mixture of ethyl 3-

methylbut-2-enoate (5 g, 39 mmol, 1 eq.) in tetra-n-butylammonium fluoride in THF (40
ml, 1 M 1 eq.) was added 2 (7.1 g, 39 mmol, 1 eq.) and the reaction was stirred at 40 oC
for 24 hours. The mixture was treated with brine and the aqueous phase was extracted with
ether. The organic phase was concentrated under vacuum and purified by chromatography
on silica gel to afford ethyl 5-(4-methoxyphenyl)-3,3-dimethyl-4-nitropentanoate, yield
33% (4 g).
1

H NMR (500 MHz, CDCl3) δ 7.10 (d, J = 8.5 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 4.94 (dd,

J = 11.9, 2.5 Hz, 1H), 4.20 (qd, J = 7.1, 5.5 Hz, 2H), 3.79 (s, 3H), 3.22 (dd, J = 14.5, 11.9
Hz, 1H), 3.06 (dd, J = 14.4, 2.5 Hz, 1H), 2.45 (s, 2H), 1.31 (t, J = 7.1 Hz, 3H), 1.27 (s, 3H),
1.22 (s, 3H).
13

C NMR (126 MHz, CDCl3) δ 170.74, 158.77, 129.78, 128.05, 114.20, 97.38, 60.61,

55.17, 43.44, 36.52, 33.52, 24.35, 23.90, 14.25.
5-(4-methoxybenzyl)-4,4-dimethylpyrrolidin-2-one (4a): Into a 25 mL round bottom
flask Raney Nickel (~1 g, 2800 Ni slurry in H2O) was added, and washed 3 times with
absolute methanol before a solution of 3 (560 mg, 1.8 mmol) in methanol (2 mL) was
added. Absolute methanol was added until total volume was approximately 10 mL, and the
open flask placed in sand within a Parr bomb. The bomb was sealed and pressurized to 65
psi with ultrapure H2 gas, and subsequently heated to 60˚C for 12 hours. At this time the
apparatus was cooled to room temperature, depressurized, and the suspension filtered
through a Celite plug while washing with methanol. The reaction mixture was concentrated
in vacuo, and the resulting clear oil was clean enough to use without further purification.

76

For further purification, the crude mixture was subjected to silica flash chromatography to
yield product as a white crystal (237 mg, 56%).
1

H NMR (500 MHz, CDCl3) δ 7.09 (d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 5.27 (s,

1H), 3.80 (s, 3H), 3.41 (dd, J = 11.4, 3.2 Hz, 1H), 2.80 (dd, J = 13.5, 3.2 Hz, 1H), 2.42 (dd,
J = 13.5, 11.4 Hz, 1H), 2.21 (s, 2H), 1.20 (s, 3H), 1.14 (s, 3H).
13

C NMR (126 MHz, CDCl3) δ 176.34, 158.53, 130.15, 129.80, 114.37, 65.33, 55.33,

46.16, 38.41, 35.91, 27.43, 22.92.
tert-butyl 2-(4-methoxybenzyl)-3,3-dimethyl-5-oxopyrrolidine-1-carboxylate (4b):
Compound 4a (186 mg, 0.8 mmol, 1 eq.) was dissolved in degassed DCM, and Boc2O (435
mg, 2 mmol, 2.5 eq.), anhydrous triethylamine (0.24 mL, 1.6 mmol, 2 eq.), and DMAP
(117 mg, 0.96 mmol, 1.2 eq.) were sequentially added. The suspension was stirred at room
temperature for 4 hours, then brought to reflux for 1 hour, after which the suspension was
cooled to room temperature. Boc2O (175 mg, 0.8 mmol, 1 eq.) and triethylamine (0.1 mL,
0.8 mmol, 1 eq.) were added, and the solution was stirred at room temperature until TLC
indicated the consumption of starting material. The solution was extracted with DCM,
washed with brine (3x), and dried with Na2SO4. The crude material was purified by silica
flash chromatography (MeOH/DCM) to yield 5b as a colorless crystal (238 mg, 90%).
1

H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 8.6 Hz, 2H), 6.85 (d, J = 8.5 Hz, 2H), 4.05 (t, J

= 6.5 Hz, 1H), 3.80 (s, 3H), 2.92 (dd, J = 14.2, 7.1 Hz, 1H), 2.81 (dd, J = 14.2, 5.9 Hz, 1H),
2.44 (d, J = 17.0 Hz, 1H), 2.13 (d, J = 17.0 Hz, 1H), 1.43 (s, 9H), 1.14 (s, 3H), 1.10 (s, 3H).
13

C NMR (126 MHz, CDCl3) δ 173.52, 158.24, 150.02, 130.35, 129.78, 113.95, 82.59,

68.08, 55.20, 45.74, 36.16, 36.06, 29.29, 27.84, 27.81, 23.14.
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tert-butyl

4-hydroxy-2-(4-methoxybenzyl)-3,3-dimethyl-5-oxopyrrolidine-1-

carboxylate (5): A solution of 4b (240 mg, 0.72 mmol, 1 eq.) in degassed THF (8 mL)
was cooled to -78˚C, and a solution of freshly prepared LDA (0.8 mL, 1.7 M in THF, 2
eq.) was added dropwise. The suspension was stirred for 15 minutes at -78˚C, then warmed
to 0˚C for 1 hour. Cooling back to -78˚C, a solution of Davis’ Oxaziridine (244 mg, 0.93
mmol, 1.3 eq.) in THF (1 M) was added dropwise. The suspension was stirred for 1 hour
at -78˚C, and 2 hours at -40˚C, at which point it was quenched with NH4Cl (aq.) and
allowed to warm to room temperature. The solution was extracted with Et2O, washed with
brine (3x) and dried with MgSO4. 7 was obtained following purification with silica flash
chromatography (MeOH/DCM) 75 mg (30%).
1

H NMR (500 MHz, CDCl3) δ 7.21 (d, J = 8.4 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 4.01 (dd,

J = 9.4, 4.4 Hz, 1H), 3.82 (s, 3H), 3.41 (dd, J = 14.1, 4.5 Hz, 1H), 2.84 (dd, J = 14.1, 9.4
Hz, 1H), 2.66 (s, 1H), 1.52 (s, 9H), 1.05 (s, 3H), 0.90 (s, 3H).
13

C NMR (126 MHz, CDCl3) δ 174.67, 158.21, 150.03, 130.29, 130.15, 113.98, 83.61,

78.77, 66.50, 55.26, 39.66, 35.39, 27.95, 26.41, 16.27.
3-hydroxy-5-(4-hydroxybenzyl)-4,4-dimethylpyrrolidin-2-one (6): To a solution of 5
(70 mg, 0.2 mmol, 1 eq.) in DCM (1.5 mL) was added BBr3 (1 mL, 1 M in DCM, 5 eq.) at
0˚C. The resulting solution was stirred for 3 hours at 0˚C, after which time TLC indicated
the consumption of starting material. Following a careful quench with NaHCO3 (aq.), the
solution was extracted with EtOAc, washed with brine (3x) and dried with MgSO4. The
compound of interest was obtained following flash chromatography on silica (5%
MeOH/DCM). 16.5 mg, 35%.
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1

H NMR (500 MHz, CDCl3) δ 7.54 (s, 1H), 7.03 (d, J = 8.4 Hz, 2H), 6.83 (d, J = 8.5 Hz,

2H), 5.48 (s, 1H), 3.96 (d, J = 2.3 Hz, 1H), 3.40 (dd, J = 11.1, 3.4 Hz, 1H), 2.97 (s, 1H),
2.80 (dd, J = 13.8, 3.4 Hz, 1H), 2.43 (dd, J = 13.9, 11.1 Hz, 1H), 1.25 (s, 3H), 0.98 (s, 3H).
13

C NMR (126 MHz, DMSO) δ 175.82, 156.12, 130.30, 129.04, 115.59, 78.07, 60.62,

44.15, 35.05, 23.91, 14.94.
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